Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ANPEP | P15144 | 2/20 | 0.47 |
| ▸ | IL1RN | P18510 | 1/20 | 0.47 |
| ▸ | ERAP2 | Q6P179 | 1/20 | 0.47 |
| ▸ | ERAP1 | Q9NZ08 | 1/20 | 0.47 |
| ▸ | PRCP | P42785 | 1/20 | 0.47 |
| ▸ | PNMT | P11086 | 1/20 | 0.41 |
| ▸ | HTR1A | P08908 | 2/20 | 0.41 |
| ▸ | HTR7 | P34969 | 2/20 | 0.41 |
| ▸ | KDR | P35968 | 1/20 | 0.40 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.40 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9463233 | 0.95 | PRCP (0.53) | ANPEPIL1RNERAP2ERAP1PRCP | |
| SCHEMBL27684703 | 0.91 | ANPEP (0.50) | ANPEPIL1RNERAP2ERAP1PRCP | |
| SCHEMBL9463238 | 0.86 | PNMT (0.50) | ANPEPIL1RNERAP2ERAP1PNMT | |
| SCHEMBL70992 | 0.81 | PNMT (0.53) | ANPEPIL1RNERAP2ERAP1PRCP | |
| SCHEMBL29809707 | 0.81 | PNMT (0.53) | ANPEPIL1RNERAP2ERAP1PRCP | |
| SCHEMBL29401802 | 0.81 | PNMT (0.53) | ANPEPIL1RNERAP2ERAP1PRCP | |
| SCHEMBL11105206 | 0.81 | ANPEP (0.54) | ANPEPIL1RNERAP2ERAP1PRCP | |
| Bromide SCHEMBL15404509 | 0.80 | PNMT (0.52) | ANPEPIL1RNERAP2ERAP1PRCP | |
| SCHEMBL27718430 | 0.80 | PNMT (0.52) | ANPEPIL1RNERAP2ERAP1PRCP | |
| SCHEMBL28425586 | 0.80 | ANPEP (0.39) | ANPEPIL1RNERAP2ERAP1PRCP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110780014-B | Method for identifying gall-containing wood by gas chromatography-mass spectrometry technology | 莆田市家具产品质量监督检验中心 | 2022-07-19 | — | — | CN | claimed |
| EP-3197510-A1 | DELIVERY SYSTEMS COMPRISING MALODOR REDUCTION COMPOSITIONS | The Procter & Gamble Company (US) | 2017-08-02 | — | — | EP | claimed |
| WO-2016049458-A1 | DELIVERY SYSTEMS COMPRISING MALODOR REDUCTION COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 2016-03-31 | — | — | WO | claimed |
| EP-4728019-A1 | A MICROWAVE CARBONIZATION ASSEMBLY AND METHOD FOR EXTRACTING COMPONENTS FROM RUBBER | Sable Rubber IP Pty Limited (AU) | 2026-04-22 | — | — | EP | disclosed |
| US-20250144161-A1 | ESSENTIAL OIL OF STEMS AND LEAVES OF CHUZHOU CHRYSANTHEMUM AND APPLICATION THEREOF | Chuzhou University (CN) | 2025-05-08 | — | — | US | disclosed |
| US-12290544-B1 | Essential oil of stems and leaves of Chuzhou chrysanthemum and application thereof | Chuzhou University (CN) | 2025-05-06 | — | — | US | disclosed |
| WO-2024257019-A1 | A MICROWAVE CARBONIZATION ASSEMBLY AND METHOD FOR EXTRACTING COMPONENTS FROM RUBBER | Molectra Rubber IP Pty Ltd (AU) | 2024-12-19 | — | — | WO | disclosed |
| US-11993562-B2 | Methods for isolation and purification of cannabidiol (CBD) and terpenes from hemp | RJ LEE GROUP, INC. (US) | 2024-05-28 | — | — | US | disclosed |
| US-20240044832-A1 | METHODS FOR DIAGNOSING CANCER BASED ON VOLATILE ORGANIC COMPOUNDS IN BLOOD AND URINE SAMPLES | TECHNION RESEARCH AND DEVELOPMENT FOUNDATION LIMITED (IL) | 2024-02-08 | — | — | US | disclosed |
| EP-4264260-A1 | METHODS FOR DIAGNOSING CANCER BASED ON VOLATILE ORGANIC COMPOUNDS IN BLOOD AND URINE SAMPLES | TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED (IL) | 2023-10-25 | — | — | EP | disclosed |
| US-11796428-B2 | Compressed open flow assay and use | ESSENLIX CORPORATION (US) | 2023-10-24 | — | — | US | disclosed |
| US-11274996-B2 | Compressed open flow assay and use | ESSENLIX CORPORATION (US) | 2022-03-15 | — | — | US | disclosed |
| US-9427425-B2 | Extracts, fractions and compositions comprising acetogenins and their applications | LAILA NUTRACEUTICALS (IN) | 2016-08-30 | — | — | US | disclosed |
| EP-2490543-B1 | EXTRACTS, FRACTIONS AND COMPOSITIONS COMPRISING ACETOGENINS AND THEIR APPLICATIONS | LAILA NUTRACEUTICALS (IN) | 2015-07-22 | — | — | EP | disclosed |
| EP-2490543-A2 | EXTRACTS, FRACTIONS AND COMPOSITIONS COMPRISING ACETOGENINS AND THEIR APPLICATIONS | Laila Nutraceuticals (IN) | 2012-08-29 | — | — | EP | disclosed |
| US-20120201884-A1 | EXTRACTS, FRACTIONS AND COMPOSITIONS COMPRISING ACETOGENINS AND THEIR APPLICATIONS | LAlLA NUTRACEUTICALS (IN) | 2012-08-09 | — | — | US | disclosed |
| WO-2011048617-A2 | EXTRACTS, FRACTIONS AND COMPOSITIONS COMPRISING ACETOGENINS AND THEIR APPLICATIONS | LAILA NUTRACEUTICALS (IN) | 2011-04-28 | — | — | WO | disclosed |
| US-20090142816-A1 | GLIOCLADIUM ISOLATE C-13 AND METHODS OF ITS USE FOR PRODUCING VOLATILE COMPOUNDS AND HYDROCARBONS | NATIONAL SCIENCE FOUNDATION | 2009-06-04 | — | — | US | disclosed |
| US-6352703-B1 | APPLYING POISON AND FEEDING STIMULANT COMPRISING NAPHTHALENE, 2,6-DI-TERT-BUTYL-4-METHYLPHENOL, ERGOSTEROL, DIOCTYL ADIPATE, AND/OR DIOCTYL PHTHALATE; INCREASED CONSUMPTION | BOARD OF SUPERVISORS OF LOUISIANA STATE UNIVERSITY AND AGRICULTURAL AND MECHANICAL COLLEGE | 2002-03-05 | — | — | US | disclosed |
| WO-1999029172-A1 | COMPOSITIONS AND METHODS FOR DETECTING AND KILLING TERMITES | BOARD OF SUPERVISORS OF LOUISIANA STATE UNIVERSITYAND AGRICULTURAL AND MECHANICAL COLLEGE (US) | 1999-06-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11993562-B2 | Methods for isolation and purification of cannabidiol (CBD) and terpenes from hemp | CNR2, CNR1, CYP8B1 | ANPEP 3680/4885IL1RN 4690/4885ERAP2 3035/4885 |
| US-20120201884-A1 | EXTRACTS, FRACTIONS AND COMPOSITIONS COMPRISING ACETOGENINS AND THEIR APPLICATIONS | TNF, IFNG, CXCL10 | ANPEP 1506/4885IL1RN 1485/4885ERAP2 2536/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.